Outsourced Pharma White Papers
-
IP Considerations In Drug Development For Biotech Companies
4/20/2026
Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.
-
The Value Of Engaging A Single CDMO For Comprehensive Biologics Services
2/4/2026
By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.
-
Assessing A Targeted Molecular Method Against Traditional In Vitro Testing For Adventitious Virus Detection
10/3/2024
Discover a CHO AOF panel that provides rapid detection of relevant adventitious viral contaminants in bulk harvest material, and explore data showing equivalent sensitivity to the in vitro assay.
-
5 Steps To Design A Microbiological Performance Qualification For Facilities
4/21/2025
Explore five steps to design an EMPQ for sterile manufacturing: classification, protocol drafting, cleaning evaluation, disinfectant efficacy testing, and continuous improvement.
-
USP <665> Becomes Official On May 1, 2026. Are You Ready?
2/24/2026
With USP <665> becoming official on May 1, 2026, proactive preparation is essential to ensure compliance and prevent delays, regulatory observations, or supply chain disruptions.
-
Filling Gaps In Drug Discovery Pipelines: From Candidate To Clinic
6/5/2026
See how existing partnerships with NIH allowed the chance to bring together government, academic, and industry resources through strategic initiatives that streamline processes and maximize benefits.
-
Cell Based Potency Assays: De-Risk Your Path With An Experienced CDMO
4/21/2026
Thorough characterization is key to unlocking the potential of antibody-based therapeutics. Leveraging a CDMO's extensive capabilities and expertise can allow you to navigate the biopharmaceutical development landscape.
-
Bioconjugates – An Increasing Diversity, A Blossoming Of Therapeutic Applications
10/24/2024
Harness the power of bioconjugation to revolutionize targeted therapies, enhance drug efficacy, and reduce side effects, paving the way for more precise and effective treatments across a range of diseases.
-
Three-Dimensional Linkage Analysis With Digital PCR For Genome Integrity
2/14/2025
A cost-effective approach with a comprehensive AAV analytical package holds the potential to advance the application of rAAV in cell and gene therapy for the treatment of human diseases.
-
Spray Dry Biologics For Oral Dosage Forms
5/15/2026
Spray drying enables stable oral delivery of biologics by creating protective dry powders, improving bioavailability, stability, and targeted release compared with traditional formulation methods.